-
Yamal on target as Spain hold off Czech Republic
-
Murakami homer propels White Sox to MLB playoff win over Guardians
-
Latvian exit polls suggest pro-European choice
-
Israel targets top Hamas leader in deadly Gaza strike on anniversary
-
Lula, Bolsonaro wrap up campaigns ahead of knife-edge election
-
Houthis say struck oil facility near Riyadh, as Saudis hit Sanaa
-
Tuchel hails 'complete' England after Croatia demolition
-
AI needs safety layers like nuclear plants: ex-OpenAI engineer
-
Fury to invite Trump to lead ring walk before Joshua showdown
-
MVP Judge will miss Yankees' MLB playoff series against Rays
-
Fashion industry in 'precarious moment', says Vivienne Westwood supremo
-
New lizard species discovered in Peru
-
Seventh heaven for England in Nations League rout of Croatia
-
Fernandes hails Portugal's 'greatest symbol' Ronaldo, calls for unity
-
Storms, flooding cause chaos on Greek holiday island of Crete
-
Grandidier-Nkanang double takes Pau to Top 14 summit despite Vannes fightback
-
#IAmJaneDoe: online support campaign in US university rape case
-
Trainer Scott gets perfect Arc boost with top notch double
-
Brazil shine on Selecao's first visit to India
-
Ex-PM says Putin cannot admit 'mistake' over Ukraine
-
Zverev sets up Djokovic quarter-final at China Open, Rybakina out
-
Houthis say Saudi Arabia launches dozens of strikes on Yemen capital
-
Happier at home, Bordeaux hammer Lyon in Top 14
-
Qatar and Abu Dhabi F1 Grand Prix to go ahead - F1 boss
-
Lula, Bolsonaro in final push for votes ahead of knife-edge election
-
South Korea lift gloom with smash-and-grab Games football gold
-
Boisterous fashion week barnstorms 'sleepy' Nigerian capital
-
Ireland news conference before Israel game cut short amid tensions
-
UAE investigators say flydubai co-pilot was planning 'terrorist act'
-
Protests over housing flare in Spain after relief measures rejected
-
Rahul smacks century in India v Windies ODI
-
Zverev thrashes Shang to set up Djokovic quarter-final at China Open
-
Daryz seeks to join exclusive club of dual Arc winners
-
Turkey football ref chief jailed pending trial for graft
-
Russia warns diplomats to leave Kyiv over new strikes threat
-
North Korea says test of intermediate-range strategic missile included use of AI
-
Olympic champ Zheng rebukes rowdy home crowd at China Open
-
Rampant Sayers leads Hong Kong to third men's rugby gold in a row
-
World No.1 Sinner pulls out of Shanghai Masters to delay return
-
Ethiopia's Tigray rebels abandon regional capital as govt advances
-
Red Bull's Verstappen grabs pole position for Bahrain GP
-
Bulgaria's Tsar Samuel returns 'home' after 1,000 years
-
India beat Pakistan in blockbuster as golfer Kim wins 'crazy' gold
-
'Glad it's over': Kim powers to Games gold and military exemption
-
India beat arch-rivals Pakistan to win Asian Games cricket gold
-
After 11 World Cups, football finally comes home for one Indian fan
-
Ethiopia's Tigray rebels abandon regional capital as govt advances: journalist
-
Marc Marquez wins sprint at Japan MotoGP, Martin grabs pole
-
Tom Kim powers to Games gold and exemption from military service
-
Alcaraz fends off Arnaldi to reach Japan Open quarters
Brazilian ritual root gets second life as potential anti-depressant
Long used in Indigenous Brazilian rituals, the jurema preta plant, which contains a potent psychedelic, is gaining ground as a potential treatment for depression.
At street stalls where medicinal herbs are sold, customers can buy the plant's root which contains dimethyltryptamine (DMT), a hallucinogenic substance that researchers say could be used to alleviate symptoms.
Following instructions he found on the internet, Guaracy Carvajal extracted DMT at home in 2016 from roots he bought on the street.
The 31-year-old software programmer, who had tried various treatment for chronic depression he has suffered since adolescence, said the drug makes it "feel like you've solved something in your life."
Physicist Draulio Araujo, who has conducted extensive research on the drug, said "the response is rapid. One day after treatment, (patients) already showed a significant improvement in their depression symptoms."
Yet he also warned that it "is not a magic cure" and that psychedelics "are not for everyone."
As a researcher at the Brain Institute of the Federal University of Rio Grande do Norte, Araujo and his team treated 14 people with the drug for six months.
The patients inhaled vaporized DMT, under medical supervision.
"It's common for our patients to say that something changed, that a key opened something," he said.
His patients also received psychological therapy, and some continued with conventional pharmaceutical drugs.
Neuroscientist Fernanda Palhano-Fontes, also of the Brain Institute, said "we have patients who improve significantly, others who don't improve at all."
Araujo's findings were published in the scientific journal Nature in April. In 2024, he published another study with promising results in the journal Psychedelic Medicine.
As for Carvajal, who stopped using jurema preta some time ago, he said the drug really allows a person to "start to have a lighter life."
It helped him get through a time when he was in "a state of questioning myself" about "work, day-to-day life," he said.
- Spiritual channels -
Brazil occupies a fairly prominent place in DMT research due to the substance's prominence in society, Araujo said.
While there is no ban on the cultivation or possession of jurema, which is also known as Mimosa tenuiflora, consumption of DMT is prohibited, except for religious and scientific use.
Jurema's roots are combined with other plants in a wine-like beverage that is consumed at rituals that include dancing and drums, part of Indigenous tradition in northeast Brazil where the plant grows.
"It's not hallucination," said Joyce Souza, a young woman attending a jurema ceremony in Planaltina, on the outskirts of Brasília.
"My spiritual channels become more accessible, I can communicate better with myself," Souza said.
Gathered in a house courtyard and dressed in white, the group of mostly novices waited for more seasoned practitioners to enter a trance and bring messages from ancient spirits.
Meanwhile, back in the lab, Araujo is hoping to expand his DMT research to a study of 100 patents.
"Let's say that in five years we'll have... a clear picture on when it will reach a real clinical setting," he said.
Ferreira--PC